drugset / Trial / NCT00540553

Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males

NCT00540553 ↗

Phase 1 Completed 126 enrolled GlaxoSmithKline
RandomizedSingle-groupDouble-blindTreatment

Summary

This research study is the first administration of GSK971086 in humans. The purpose of this study is to assess the safety and tolerability of GSK971086, as well as, how much GSK971086 is in your blood after different doses

Timeline

Start
2007-08
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK971086 Unknown — —

Indications